Browsing by Author "Vogel, A."

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation
    (SAGE PUBLICATIONS LTD, 2007) Cavagnaro, F.; Kattan, J.; Godoy, L.; Gonzalez, A.; Vogel, A.; Rodriguez, J. I.; Faunes, M.; Fajardo, C.; Becker, P.
    Extracorporeal membrane oxygenation (ECMO) is a therapy that ensures adequate tissue oxygen delivery in patients suffering cardiac and/or respiratory failure that are unresponsive to conventional therapy. During ECMO, it is common to see a decrease in urine output that may be associated with acute renal failure. In this context, continuous renal replacement therapy (CRRT) should be considered. Our aim is to evaluate a pioneer experience in Latin America, related to the use of CRRT in a group of neonatal-pediatric patients during ECMO. We conducted a retrospective review of patients treated with ECMO at our institution between May 2003 and May 2005. Twelve infants were treated with ECMO, six of them also underwent CRRT The main reasons for CRRT initiation were fluid overload and progressive azotemia. Observed complications were clots in the filter and excessive ultraffitration. CRRT was successful in fluid management and solute clearance in all patients. Discharge survival rate was 83%, all of them with normal renal function. Concurrent CRRT with ECMO is technically feasible and efficacious in the management of fluid overload and solute clearance. We report the first experience with these therapies in a Latin American neonatalpediatric ECMO program associated with the Extracorporeal Life Support Organization.
  • Thumbnail Image
    Item
    Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures
    (CLINICAL & EXPER RHEUMATOLOGY, 2007) Reyes, M. L.; Hernandez, M. I.; King, A.; Vinet, A. M.; Vogel, A.; Lagomarsino, E.; Mericq, M. V.; Mendez, C.; Gederlini, A.; Talesnik, E.
    To identify factors that contribute to a decreased Z score of volumetric spine bone mineral density (ZvSBMD) and the development of vertebral fractures (VF) in children receiving chronic systemic corticosteroid therapy (SCT); to describe their outcome after 2 years, and to define predictive threshold values for ZvSBMD for VF.
  • Thumbnail Image
    Item
    Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis : A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network
    (2019) Schaefer, F.; Benner, L.; Borzych-Duzalka, D.; Zaritsky, J.; Xu, H.; Rees, L.; Antonio, Z.L.; Serdaroglu, E.; Hooman, N.; González Celedón, Claudia María; Patel, H.; Sever, L.; Vondrak, K.; Flynn, J.; Rebori, A.; Wong, W.; Holtta, T.; Yildirim, Z.Y.; Ranchin, B.; Grenda, R.; Testa, S.; Drozdz, D.; Szabo, A.J.; Eid, L.; Basu, B.; Vitkevic, R.; Wong, C.; Pottoore, S.J.; Muller, D.; Dusunsel, R.; Celedon, C.G.; Fila, M.; Sartz, L.; Sander, A.; Warady, B.A.; Adragna, M.; Coccia, P.A.; Suarez, A.; Valles, P.G.; Salim, R.; Alconcher, L.; Arbeiter, K.; van Hoeck, K.; Koch, V.; Feber, J.; Harvey, E.; White, C.; Valenzuela, M.; Villagra, J.; Cano, F.; Contreras, M.A.; Vogel, A.; Zambrano, P.; Hevia, P.; Chiu, M.C.; Ding, J.; Vanegas, J.J.; Higuita, L.M.; Roussey, G.; Ulinski, T.; Krid, S.; Fischbach, M.; Harambat, J.; Samaille, C.; Buscher, R.; Oh, J.; Pape, L.; John, U.; Klaus, G.; Billing, H.; Stafanidis, C.; Papachristou, F.; Bagga, A.; Kanitkar, M.; Sinha, R.; Sethi, S.; Verrinam, E.; Vidal, E.; Leozappa, G.; Landau, D.; Ha, I.S.; Paik, K.H.; Bilal, A.; Sahpazova, E.; Lim, Y.N.; Barbosa, L.S.; Groothoff, J.W.; Konijenberg, Y.; Silva, Y.; Al Ryami, M.; Munarriz, R.L.; Leszepanska, B.; Szczepanska, M.; Brumariu, O.; Kari, J.; Kruscic, D.; Yap, H.K.; Ariceta, G.; Aguirre, M.; Santos, F.; Niwhiska-Faryna, B.; Bayazit, A.; Bakkaloglu, C.A.S.; Bakkaloglu, S.; Bilge, I.; Yavascan, O.; Mir, S.; Simkova, E.; Christian, M.; Greenbaum, L.; Neu, A.; Askenazi, D.; Al-Akash, A.; Swartz, S.; Brophy, P.; Rheault, M.; Pradhan, M.
  • No Thumbnail Available
    Item
    Latin American Registry of Pediatric Renal Transplantation 2004-2008
    (2010) Goulart, P.; Koch, P.; Medina-Pestana, J.; Garcia, C.; Bittencourt, V.; Medeiros, M.; Munoz, R.; Delucchi, A.; Lillo, A. M.; Ariza, M.; Bosque, M.; Carvalho, D.; Matuck, T.; Meneses, R.; Fontes, J.; Monteiro, D. C.; Neto, E. Davi; Pinto, V.; Salas, P.; Prates, L.; Belanguero, V.; Pereira, L.; Lima, E.; Penido, J. M.; Benini, V.; Laranjo, S.; Silva, J. M.; Orta, N.; Coronel, V.; Cisneros, A.; Arriaga, J.; Sebastian, M. J.; Abbud-Filho, M.; Fernandez, I.; Gastelbondo, R.; Medjia, N.; Rosati, P.; Hevia, P.; Baptista, M. A.; Ramalho, H.; Diaz, M.; Monteverde, M.; Ferraris, J.; Repetto, H.; Exeni, R.; Florentin, L.; Florin, J.; Cazorla, N.; Casadei, D.; Melendez, K.; Calderon, R.; Silva, V.; Patino, J.; Palacio, D.; Madrigal, G.; Sandoval, M.; Urbina, C.; Loza, R.; Cavagnaro, F.; Vogel, A.; Jimenez, W.; Lou, R.; Rodriguez, C.; Aguilar, C.; Galvez, H.; Rodriguez, L.; Paladini, J.; Agusti, J.; Puelma, F.; Troche, A.; Martinez-Pico, M.; Higueras, W.; Liendo, C.; Restrepo, J.; Caicedo, L. A.; Socorro, F.; Semprum, P.
    The Latin American Pediatric Nephrology Association (ALANEPE) reports the first regional kidney transplant registry in Latin America. A mean range of 75%, 30% to 100% renal transplant recipients under 21 yr old were included. Out of 20 countries invited to participate, 14 performed renal transplant, 11 had universal financial support from their governments. The centers included: Brazil (9), Argentina (4), Chile (4), Venezuela (3), Mexico (2), and one in: Cuba, Colombia, Costa Rica, Nicaragua, Guatemala, Ecuador, Honduras, Paraguay and Peru. The registry included 1458 patients, average of 291 per year, 55% male. Mean follow-up 23.4 +/- 17 months; mean age was 11.7 +/- 4.3 yr (1-21), 11% under five yr of age. Etiology: uropathy/ reflux nephropathy 27%, glomerulopathies 24% (included 12% FSGS), hypo/dysplasia (11%), vascular (6%), congenital/hereditary (5%), unknown (19%). Induction therapy: 71% anti-IL2RAb, 13% ATG/TIMO, 14% non-induction. Maintenance therapy: Tacrolimus 64%, Cyclosporine 32%, MMF 54%, MPS 20%, noTORi 96%, steroids 90%, withdrawal or steroid avoidance 10%. Loss of graft 155/1458 (11%), death with functioning graft (3.4%), vascular thrombosis (2.8%), acute rejection (2.8%), recurrence of disease (1%). Forty-eight patients died (3.3%); infection was the main cause 23 (2.1%). Global patient survival rate at one, three, and five yr was 97%, 96%, and 96%. Graft survival rate at one, three, and five yr LRD was 96%, 93% and 89%; for DD 92%, 86% and 76% respectively. Both survival rates were higher in LRD (p < 0.008 and p < 0.001). A pediatric renal transplant study has started, making information available to be shared between the centers and the world.